tirzepatide effects on liver for Weight Loss (Fat Loss) Tirzepatide for MASH with Liver

Conclusion We performed a single centre retrospective observational study on the efficacy of the GLP1-RAs liraglutide and semaglutide in reducing weight in 50 patients with weight regain after bariatric surgery

Sustainable weight loss through supportive management of medical, hormonal, and behavioral triggers

secondary endpoints included overall survival and the amount of time until a patients pain got worse

Conclusion: In subjects with obesity and high ALT, semaglutide 0.2-0.4 mg daily reduced ALT to an extent that was broadly comparable across weight loss categories, and resulted in dose-related ALT normalization in up to 46% of subjects after 52 weeks

Tirzepatide BNF (NICE)

It is not well understood, and there is no confirmed mechanism